Document:

EXHIBIT 4.4
                                                                     -----------

THE  WARRANT  AND  THE  SECURITIES   ISSUABLE  UPON  EXERCISE  OF  THIS  WARRANT
(COLLECTIVELY,  THE "SECURITIES")  HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR UNDER ANY STATE SECURITIES OR
BLUE  SKY LAWS  ("BLUE  SKY  LAWS").  NO  TRANSFER,  SALE,  ASSIGNMENT,  PLEDGE,
HYPOTHECATION  OR OTHER  DISPOSITION  OF THIS WARRANT OR THE  SECURITIES  OR ANY
INTEREST  THEREIN MAY BE MADE EXCEPT (A) PURSUANT TO AN  EFFECTIVE  REGISTRATION
STATEMENT  UNDER THE SECURITIES  ACT AND ANY APPLICABLE  BLUE SKY LAWS OR (B) IF
THE COMPANY HAS BEEN  FURNISHED  WITH BOTH AN OPINION OF COUNSEL FOR THE HOLDER,
WHICH OPINION AND COUNSEL SHALL BE  SATISFACTORY  TO THE COMPANY,  TO THE EFFECT
THAT NO  REGISTRATION  IS REQUIRED  BECAUSE OF THE  AVAILABILITY OF AN EXEMPTION
FROM  REGISTRATION  UNDER THE SECURITIES  ACT AND APPLICABLE  BLUE SKY LAWS, AND
ASSURANCES THAT THE TRANSFER, SALE, ASSIGNMENT,  PLEDGE,  HYPOTHECATION OR OTHER
DISPOSITION  WILL BE MADE ONLY IN  COMPLIANCE  WITH THE  CONDITIONS  OF ANY SUCH
REGISTRATION OR EXEMPTION.

                   WARRANT TO PURCHASE SHARES OF COMMON STOCK
                                       OF
                             PROUROCARE MEDICAL INC.

Warrant No. 22                                               Plymouth, Minnesota
                                                                   July 19, 2004

     THIS CERTIFIES THAT, for value received,  Vladimir Drits, or its successors
or assigns (collectively,  the "Holder") is entitled to purchase from ProUroCare
Medical Inc. (the "Company"), Ten Thousand (10,000) fully paid and nonassessable
shares (the  "Shares") of the  Company's  common  stock,  $.00001 par value (the
"Common  Stock"),  at an exercise  price of Two  Dollars and No/100  ($2.00) per
Share (the "Exercise  Price"),  subject to adjustment as herein  provided.  This
warrant shall be  exercisable  only to the extent that all, or any part thereof,
has vested in the Holder.  This  Warrant may be  exercised by Holder at any time
after the date hereof;  provided,  however,  that, Holder shall in no event have
the right to exercise this Warrant or any portion  thereof after five years from
the date hereof, at which time all of Holder's rights hereunder shall expire.

     This Warrant is subject to the following provisions, terms and conditions:

     1.  Vesting.  The warrant  shall vest on a pro rata basis in equal  monthly
installments  over a thirty-six (36) month period,  beginning on the date of the
first  month  anniversary  of the date of this  warrant and  continuing  on each
monthly anniversary date (hereinafter referred to singularly as a "Vesting Date"
and collectively as "Vesting Dates") until the warrant is fully vested.

     2.  Exercise  of Warrant.  The rights  represented  by this  Warrant may be
exercised  by the  Holder,  in  whole or in part  (but not as to any  fractional
shares of Common Stock), by the surrender of this Warrant (properly endorsed, if
required,  at the Company's  principal  office in Plymouth,  Minnesota,  or such
other office or agency of the Company as the Company may  designate by notice in
writing to the Holder at the  address of such Holder  appearing  on the books of
the Company at any time within the period above  named),  and upon payment to it
by certified  check,  bank draft or cash of the purchase  price for such Shares.
The Company agrees that the Shares so purchased  shall be deemed to be issued to
the Holder as the record owner of such Shares as of the close of business on the
date on which this  Warrant

<PAGE>

shall have been  surrendered and payment for such Shares shall have been made as
aforesaid.  Certificates  for the Shares so purchased  shall be delivered to the
Holder  within a  reasonable  time,  not  exceeding  30 days,  after the  rights
represented  by this  Warrant  shall have been so  exercised  and,  unless  this
Warrant has expired,  a new Warrant  representing the number of Shares,  if any,
with respect to which this Warrant shall not then have been exercised shall also
be  delivered to the Holder  within such time.  The Company may require that any
such new  Warrant or any  certificate  for Shares  purchased  upon the  exercise
hereof bear a legend  substantially  similar to that which is  contained  on the
face of this Warrant.

     3.  Transferability  of this  Warrant.  This  Warrant  is  issued  upon the
following terms, to which Holder consents and agrees:

     (a) Until this  Warrant is  transferred  on the books of the  Company,  the
Company will treat the Holder of this  Warrant,  registered as such on the books
of the Company,  as the absolute  owner hereof for all purposes  without  effect
given to any notice to the contrary.

     (b) This  Warrant  may not be  exercised,  and this  Warrant and the Shares
underlying this Warrant shall not be transferable, except in compliance with all
applicable state and federal  securities laws,  regulations and orders, and with
all other applicable laws, regulations and orders.

     (c) The  Warrant  may not be  transferred,  and the  Shares  issuable  upon
exercise of this Warrant, may not be transferred without the Holder obtaining an
opinion of counsel,  which opinion and counsel are  satisfactory to the Company,
stating  that  the  proposed   transaction  will  not  result  in  a  prohibited
transaction  under the Securities Act and applicable Blue Sky Laws. By accepting
this Warrant, the Holder agrees to act in accordance with any conditions imposed
on such transfer by any such opinion of counsel.

     (d) Neither the  issuance  of this  Warrant nor the  issuance of the Shares
issuable upon exercise of this Warrant have been registered under the Securities
Act.

     4. Certain Covenants of the Company.  The Company covenants and agrees that
all Shares  which may be issued upon the exercise of the rights  represented  by
this Warrant,  upon issuance and full payment for the Shares so purchased,  will
be duly authorized and issued,  fully paid and  nonassessable  and free from all
taxes, liens and charges with respect to the issue hereof, except those that may
be created by or imposed upon the Holder or its property;  and, without limiting
the generality of the foregoing,  the Company  covenants and agrees that it will
from time to time take all such  actions as may be  required  to ensure that the
par value per share of the  Common  Stock is at all times  equal to or less than
the Exercise  Price per Share  issuable  pursuant to this  Warrant.  The Company
further  covenants  and agrees  that during the period  within  which the rights
represented by this Warrant may be exercised, the Company will at all times have
authorized and reserved,  free of preemptive or other rights, for the purpose of
issue  upon  exercise  of the  purchase  rights  evidenced  by this  Warrant,  a
sufficient number of shares of its Common Stock to provide for the full exercise
of the rights represented by this Warrant.

     5.  Adjustment of Exercise  Price and Number of Shares.  The Exercise Price
and number of Shares are subject to the following adjustments:

     (a) Stock Dividend, Stock Split or Stock Combination.  If (i) any dividends
on any  class  of the  Company's  capital  stock  payable  in  Common  Stock  or
securities  convertible  into or  exercisable  for Common  Stock  (collectively,
"Common Stock Equivalents") shall be paid by the Company, (ii) the Company shall
divide its  then-outstanding  shares of Common  Stock  into a greater  number of
shares,  or (iii) the Company  shall  combine its  outstanding  shares of Common
Stock, by reclassification  or otherwise,  then, in any such event, the Exercise
Price in effect  immediately  prior to such event shall  (until

                                       2

<PAGE>

adjusted again pursuant  hereto) be adjusted  immediately  after such event to a
price  (calculated  to the nearest  full cent) equal to the  quotient of (x) the
number of shares of Common Stock  outstanding  immediately  prior to such event,
multiplied  by the  Exercise  Price in effect  immediately  prior to such event,
divided  by  (y)  the  total  number  of  shares  of  Common  Stock  outstanding
immediately  after such event. No adjustment of the Exercise Price shall be made
if the amount of such adjustment shall be less than $.05 per Share; but any such
adjustment  not required  then to be made shall be carried  forward and shall be
made at the  time and  together  with the any  subsequent  adjustment(s)  which,
together with any  adjustment(s)  so carried  forward,  shall amount to not less
than $.05 per Share.

     (b) Number of Shares Issuable on Exercise of Warrants. Upon each adjustment
of the Exercise  Price  pursuant to this  Section,  the Holder shall  thereafter
(until  another  such  adjustment)  be entitled  to  purchase,  at the  adjusted
Exercise  Price,  the number of Shares,  calculated  to the nearest  full Share,
equal to the  quotient of (i) the  product of (A) the number of Shares  issuable
under this  Warrant  (as then  adjusted  pursuant  hereto  prior to the  current
adjustment),  multiplied  by (B) the  Exercise  Price  in  effect  prior to such
adjustment, divided by (ii) the adjusted Exercise Price.

     (c) Notice of Adjustment. Upon any adjustment of the Exercise Price and any
increase or decrease in the number of Shares of Common Stock  issuable  upon the
exercise of the Warrant,  then,  and in each such case, the Company shall within
30 days  thereafter give written notice thereof,  by first-class  mail,  postage
prepaid, addressed to each Holder as shown on the books of the Company. Any such
notice shall state the  adjusted  Exercise  Price and adjusted  number of Shares
issuable  upon the  exercise of the Warrant,  and shall set forth in  reasonable
detail the methods of calculation of such  adjustments  and the facts upon which
such calculations were based.

     (d) Effect of  Reorganization,  Reclassification  or Merger. If at any time
while this Warrant is outstanding there should be (i) any  reorganization of the
Company's  capital  stock  (other than splits or  combinations  of Common  Stock
contemplated  by and provided for in Section 5(a)),  (ii) any  consolidation  or
merger of the Company  with  another  corporation,  limited  liability  company,
partnership or other business entity,  or any sale,  conveyance,  lease or other
transfer by the Company of all or substantially all of its property to any other
corporation,  limited liability  company,  partnership or other business entity,
which is effected  in such a manner  that the  holders of Common  Stock shall be
entitled to receive  cash,  stock,  securities  or assets with  respect to or in
exchange for Common Stock, or (iii) any dividend or any other  distribution upon
any class of the Company's capital stock payable in capital stock of a different
class,  other  securities of the Company,  or other Company property (other than
cash),  then, as a part of such  transaction,  lawful provision shall be made so
that  Holder  shall have the right  thereafter  to  receive,  upon the  exercise
hereof,  the number of shares of stock or other  securities  or  property of the
Company or of the successor entity resulting from a consolidation or merger,  or
of the entity to which the  property  of the  Company  has been sold,  conveyed,
leased or otherwise transferred, as the case may be, which the Holder would have
been entitled to receive upon such capital  reorganization,  reclassification of
capital stock, consolidation, merger, sale, conveyance, lease or other transfer,
if  this  Warrant  had  been  exercised   immediately   prior  to  such  capital
reorganization,  reclassification of capital stock, consolidation, merger, sale,
conveyance,  lease or other transfer. In any such case, appropriate  adjustments
(as  determined  by the  Company's  board  of  directors)  shall  be made in the
application of the provisions of this Warrant to the end that the provisions set
forth herein shall  thereafter be  applicable,  as near as reasonably may be, in
relation  to any  shares  or  other  property  thereafter  deliverable  upon the
exercise of the Warrant as if the Warrant had been exercised  immediately  prior
to  such  capital  reorganization,   reclassification  of  capital  stock,  such
consolidation,  merger, sale, conveyance, lease or other transfer and the Holder
had  carried  out the terms of the  exchange  as  provided  for by such  capital
reorganization,  consolidation or merger.  The Company shall not effect any such
capital reorganization,  consolidation, merger or transfer unless, upon or prior
to the  consummation  thereof,  the successor  entity or the entity to which the
property of the Company has been sold, conveyed, leased or otherwise transferred
shall assume in writing the  obligation  to deliver to the Holder such shares of
stock,  securities,  cash or  property  which the Holder  shall be  entitled  to
purchase in accordance with the foregoing provisions.

                                       3

<PAGE>

     6. No Rights as  Shareholder.  This  Warrant  shall not  entitle the Holder
hereof to any voting rights or other rights as a shareholder of the Company.

     7.  Governing  Law.  This  Warrant  shall be governed by and  construed  in
accordance  with  the laws of the  State  of  Minnesota  without  regard  to its
conflicts-of-law provisions.

     8.  Amendments  and  Waivers.  The  provisions  of this  Warrant may not be
amended, modified or supplemented, and waiver or consents to departures from the
provisions hereof may not be given, unless the Company agrees in writing and has
obtained the written consent of the Holder.

     9.  Successors  and Assigns.  All the terms and  conditions of this Warrant
shall be binding upon and inure to the benefit of the permitted  successors  and
assigns of the Company and Holder.

     10.  Headings  and  References.  The  headings  of  this  Warrant  are  for
convenience only and shall not affect the interpretation of this Warrant. Unless
the  context  indicates  otherwise,   all  references  herein  to  Sections  are
references to Sections of this Warrant.

     11.  Notices.  All notices or  communications  hereunder,  except as herein
otherwise specifically provided, shall be in writing. Notices sent to the Holder
shall be mailed, hand delivered or faxed and confirmed to the Holder at his, her
or its address set forth in the Company's  records.  Notices sent to the Company
shall be mailed,  hand  delivered or faxed and confirmed to  ProUroCare  Medical
Inc., One Carlson  Parkway,  Suite 124,  Plymouth,  Minnesota  55447, or to such
other address as the Company or the Holder shall notify the other as provided in
this Section.

     IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its
duly authorized officer on the date first set forth above.

PROUROCARE MEDICAL INC.

By:  /s/Michael Grossman
  --------------------------------------
  MICHAEL P. GROSSMAN, President and CEO

ATTEST:

By:  /s/Richard Thon
  --------------------------------------
  RICHARD THON, Chief Financial Officer

                                       4EXHIBIT 4.5
                                                                     -----------

THE SECURITY  EVIDENCED  HEREBY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933 OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED,
OFFERED, PLEDGED OR OTHERWISE DISTRIBUTED FOR VALUE UNLESS THERE IS AN EFFECTIVE
REGISTRATION  STATEMENT  UNDER SUCH ACT OR LAWS  COVERING  SUCH  SECURITY OR THE
COMPANY  RECEIVES  AN  OPINION  OF  COUNSEL  FOR THE  HOLDER  OF  THIS  SECURITY
(CONCURRED  IN BY COUNSEL FOR THE  COMPANY)  STATING  THAT SUCH SALE,  TRANSFER,
ASSIGNMENT,   PLEDGE  OR  DISTRIBUTION  IS  EXEMPT  FROM  THE  REGISTRATION  AND
PROSPECTUS  DELIVERY  REQUIREMENTS  OF  THE  SECURITIES  ACT  OF  1933  AND  ALL
APPLICABLE STATE SECURITIES LAWS.

                                 FORM OF WARRANT
                                       FOR
                             SHARES OF COMMON STOCK
                                       OF
                                 PROUROCARE INC.

     For value  received,  ____________________,  or its  successors  or assigns
("Holder"),  is entitled to subscribe for and purchase from  ProUroCare  Inc., a
Minnesota   corporation   (the   "Company"),   up  to  _______  fully  paid  and
nonassessable  shares of the Company's  common  stock,  $.01 par value per share
(the "Common Stock"),  or such greater or lesser number of such shares as may be
determined by application of the  anti-dilution  provisions of this warrant,  at
the price of $7.00  per  share,  subject  to  adjustments  as noted  below  (the
"Warrant Exercise Price").

     This warrant may be exercised by Holder at any time or from time to time on
or prior to the fifth anniversary of the date hereof.

     This warrant is subject to the following provisions, terms and conditions:

     1. The rights  represented  by this warrant may be exercised by the Holder,
in whole or in part, by written  notice of exercise  delivered to the Company at
least three days prior to the intended  date of exercise and by the surrender of
this warrant  (properly  endorsed if required)  at the  principal  office of the
Company and, except in connection  with a Cashless  Exercise (as defined below),
upon payment to it by cash,  certified check or bank draft of the purchase price
for such shares.  The shares so purchased shall be deemed to be issued as of the
close of business on the date on which this  warrant has been  exercised  by its
surrender and,  except in connection  with a Cashless  Exercise,  payment to the
Company of the Warrant  Exercise Price.  Certificates for the shares of stock so
purchased,  bearing  the  restrictive  legend  set  forth in  Section  5 of this
warrant,  shall be  delivered  to the  Holder  within 15 days  after the  rights
represented  by this  warrant  shall have been so  exercised,  and,  unless this
warrant has expired,  a new warrant  representing the number of shares,  if any,
with  respect  to which  this  warrant  has not  been  exercised  shall  also be
delivered to the Holder within such time.  No fractional  shares shall be issued
upon the exercise of this warrant.

     At the option of the Holder,  payment of the Warrant  Exercise Price may be
made through a net exercise  without  payment of the Warrant  Exercise  Price in
cash by the Holder providing  notice to the Company of the Holder's  election to
receive a number of shares of Common  Stock in a cashless  exercise (a "Cashless
Exercise").  Upon receipt of a notice of Cashless  Exercise,  the Company  shall
deliver  to the  Holder  (without  cash  payment  by the  Holder of any  Warrant
Exercise  Price)  that  number of shares  of Common  Stock  that is equal to the
quotient  obtained by dividing (x) the value of the portion of the warrant being
exercised on the date that the warrant shall have been  surrendered  (determined
by subtracting the aggregate  Warrant Exercise Price for the number of shares of
Common Stock as to which

<PAGE>

the  warrant  is being  exercised  from the  aggregate  Fair  Market  Value  (as
hereinafter  defined) of such number of shares of Common Stock), by (y) the Fair
Market Value of one share of Common Stock.  A notice of Cashless  Exercise shall
state the  number of shares  of Common  Stock as to which the  warrant  is being
exercised.  "Fair  Market  Value" for  purposes of this  Section  shall mean the
average of the Common Stock closing prices reported by the principal exchange on
which the Common  Stock is traded,  or the last sale  prices as  reported by the
National  Association of Securities  Dealers,  Inc.  Automated  Quotation System
("Nasdaq")  National Market or SmallCap Market,  as the case may be, for the ten
(10)  business days  immediately  preceding the date that the warrant shall have
been  surrendered  or, in the event no public  market shall exist for the Common
Stock at the time of such  cashless  exercise,  Fair Market Value shall mean the
fair market  value of the Common  Stock as the same shall be  determined  in the
good  faith  discretion  of  the  Company's  Board  of  Directors,   after  full
consideration  of all factors then deemed relevant by such Board of Directors in
establishing  such value,  including by way of illustration  and not limitation,
the per share  purchase  price of the most recent sale of shares of Common Stock
by the Company after the date hereof,  as evidenced by the vote of a majority of
the directors then in office.  Following a Cashless Exercise,  the warrant shall
be  canceled in all  respects  with regard to (a) the number of shares of Common
Stock issued in  accordance  with the cashless  exercise  plus (b) the number of
shares of Common Stock used as consideration for the Cashless Exercise.

     2. The Company covenants and agrees that all shares that may be issued upon
the exercise of the rights represented by this warrant shall, upon issuance,  be
duly authorized and issued,  fully paid and  nonassessable  shares.  The Company
further  covenants  and agrees  that during the period  within  which the rights
represented by this warrant may be exercised, the Company will at all times have
authorized,  and reserved for the purpose of issue or transfer  upon exercise of
the subscription rights evidenced by this warrant, a sufficient number of shares
of Common  Stock to provide for the exercise of the rights  represented  by this
warrant.

     3. The Warrant  Exercise Price shall be subject to adjustment  from time to
time as hereinafter provided in this section 3.

     (a) If the Company at any time divides the outstanding shares of its Common
Stock into a greater number of shares (whether pursuant to a stock split,  stock
dividend or otherwise),  and conversely, if the outstanding shares of its Common
Stock are combined into a smaller number of shares,  the Warrant  Exercise Price
in  effect   immediately   prior  to  such  division  or  combination  shall  be
proportionately  adjusted to reflect the  reduction  or increase in the value of
each such Common Stock.

     (b) If any capital  reorganization or reclassification of the capital stock
of the  Company,  or  consolidation  or  merger  of  the  Company  with  another
corporation,  or the sale of all or  substantially  all of its assets to another
corporation  shall be  effected in such a way that  holders of the Common  Stock
shall be entitled to receive  stock,  securities or assets with respect to or in
exchange for such Common  Stock,  then,  as a condition of such  reorganization,
reclassification, consolidation, merger or sale, the Holder shall have the right
to  purchase  and  receive  upon the basis  and upon the  terms  and  conditions
specified  in this  warrant  and in  lieu  of the  shares  of the  Common  Stock
immediately  theretofore  purchasable  and  receivable  upon the exercise of the
rights represented  hereby,  such shares of stock, other securities or assets as
would  have been  issued or  delivered  to the Holder if it had  exercised  this
warrant  and  had   received   such  shares  of  Common   Stock  prior  to  such
reorganization, reclassification, consolidation, merger or sale.

     (c) In the event that the  purchase  price for any sale of Common  Stock in
the  Company's  offering of Common Stock  pursuant to the  Confidential  Private
Placement Memorandum dated December 2, 2002, as the same may have been or may be
amended  from time to time (the  "Offering"),  is less than $9.50 per share (the
"Offering  Price"),  then the Warrant Exercise Price in effect immediately prior
to such

                                       2
<PAGE>

sale shall be reduced by a percentage of the Warrant Exercise Price equal to the
percentage reduction in the Offering Price; provided,  however, that in no event
shall the Warrant  Exercise Price be reduced pursuant to this Section 3(c) to an
amount  less than $5.00 per share.  For  example,  if the  Company  were to sell
shares of Common Stock in the Offering at a purchase price equal to $8.55 (a 10%
reduction  in the  Offering  Price),  then the Warrant  Exercise  Price would be
reduced by $.70 (10% of the Warrant Exercise Price in effect  immediately  prior
to such sale, assuming no previous adjustment to the Warrant Exercise Price); or
if the Company were to sell shares of Common Stock in the Offering at a purchase
price equal to $6.65 (a 30% reduction in the Offering  Price),  then the Warrant
Exercise  Price  would  be  reduced  to $5.00 (a 30%  reduction  in the  Warrant
Exercise Price in effect  immediately prior to such sale would result in a $2.10
decrease in the Warrant  Exercise Price,  but pursuant to this Section 3(c), the
Warrant  Exercise  Price may not be  reduced  to an amount  less than  $5.00 per
share).

     (d) Upon each adjustment of the Warrant  Exercise  Price,  the Holder shall
thereafter be entitled to purchase, at the Warrant Exercise Price resulting from
such  adjustment,  the number of shares  obtained  by  multiplying  the  Warrant
Exercise Price in effect  immediately  prior to such adjustment by the number of
shares  purchasable  pursuant  hereto  immediately  prior to such adjustment and
dividing the product  thereof by the Warrant  Exercise Price resulting from such
adjustment  as computed  without  regard to the $5.00  limitation as per Section
3(c).

     (e) Upon any adjustment of the Warrant  Exercise  Price,  the Company shall
give written notice thereof, by first class mail, postage prepaid,  addressed to
the registered  Holder of this warrant at the address of such Holder as shown on
the books of the Company,  which notice shall state the Warrant  Exercise  Price
resulting  from such  adjustment  and the increase or  decrease,  if any, in the
number of shares  purchasable  at such price upon the exercise of this  warrant,
setting forth in reasonable  detail the method of calculation and the facts upon
which such calculation is based.

     4. This warrant  shall not entitle the Holder to any voting rights or other
rights as a shareholder of the Company.

     5. Application of Restrictions of Transfer.

     (a) No transfer of this warrant may be  completed  unless and until (i) the
Company has received an opinion of counsel for the Company that such  securities
may be sold pursuant to an exemption from registration  under the Securities Act
of 1933, as amended (the  "Securities  Act"),  or (ii) a registration  statement
relating to this warrant has been filed by the Company and declared effective by
the Commission.  Subject to the foregoing, this warrant and all rights hereunder
are transferable, in whole or in part, at the principal office of the Company by
the Holder in person or by duly  authorized  attorney,  upon  surrender  of this
warrant properly endorsed to any person or entity who represents in writing that
he/she/it is acquiring  the warrant for  investment  and without any view to the
sale or other distribution  thereof.  Each Holder of this warrant,  by taking or
holding  the same,  consents  and agrees that the bearer of this  warrant,  when
endorsed,  may be treated by the Company and all other persons dealing with this
warrant as the absolute owner hereof for any purpose and as the person  entitled
to exercise the rights  represented  by this warrant or perform the  obligations
required  hereby,  or to the transfer  hereof on the books of the  Company,  any
notice to the contrary  notwithstanding;  but until such transfer on such books,
the Company may treat the registered owner hereof as the owner for all purposes.

     (b) In no event shall the  Holder(s)  sell any shares of Common  Stock that
are issued upon the exercise of the rights  represented  by this warrant  within
180 days  following  the  effective  date of an initial  public  offering of the
Common Stock of the Company.

                                       3
<PAGE>

     (c) Each  certificate  for shares  issued  upon the  exercise of the rights
represented  by this  warrant  shall  bear a legend as  follows  unless,  in the
opinion of counsel  to the  Company,  such  legend is not  required  in order to
ensure compliance with the Securities Act:

      "THESE  SHARES  HAVE BEEN  PURCHASED  FOR  INVESTMENT  WITHIN THE
      MEANING OF THE  SECURITIES  ACT OF 1933,  AS AMENDED (THE "ACT"),
      AND APPLICABLE  STATE  SECURITIES LAWS, AND THEY MAY NOT BE SOLD,
      OFFERED FOR SALE,  PLEDGED OR  OTHERWISE  TRANSFERRED  WITHOUT AN
      EFFECTIVE  REGISTRATION  STATEMENT  UNDER THE ACT AND  APPLICABLE
      STATE  SECURITIES  LAWS OR AN OPINION OF COUNSEL  SATISFACTORY TO
      THE CORPORATION TO THE EFFECT THAT THE PROPOSED  TRANSACTION WITH
      BE EXEMPT FROM  REGISTRATION.  IN  ADDITION,  IN NO EVENT MAY THE
      SECURITIES  REPRESENTED  BY THIS  CERTIFICATE  BE PUBLICLY  SOLD,
      TRANSFERRED,  ASSIGNED, OFFERED, PLEDGED OR OTHERWISE DISTRIBUTED
      FOR VALUE WITHIN 180 DAYS  FOLLOWING  THE  EFFECTIVE  DATE OF THE
      INITIAL PUBLIC OFFERING OF COMMON STOCK BY THE COMPANY."

     6.  Neither  this  warrant  nor any term  hereof  may be  changed,  waived,
discharged or terminated  orally but only by an instrument in writing  signed by
the  party  against  which  enforcement  of the  change,  waiver,  discharge  or
termination is sought.

     IN WITNESS  WHEREOF,  the Company has caused this  warrant to be signed and
delivered by its duly authorized officer.

Dated:  ______________, 2003.                PROUROCARE INC.:

                                             By:
                                               ---------------------------------
                                             Name:
                                                 -------------------------------
                                             Title:
                                                  ------------------------------

                                       4
<PAGE>

                 HOLDERS OF WARRANTS PURSUANT TO LOAN GUARANTEES

                                                   COMMON SHARES
                                                    SUBJECT TO
WARRANT HOLDER NAME                                  WARRANTS
------------------------------------------------- ---------------

Henry Cousineau III                                   339,282

Stanford Baratz Revocable Trust u/a/d 9/7/94          135,720

David Kunin                                           101,790

David Koenig                                           67,860

Anita Kunin                                            33,936

Leon Steinberg                                         50,895

Michael & Margaret Provenzano                          67,860

Tim Olson                                              33,930

Steve Burke                                           186,609
------------------------------------------------- ---------------

Total                                               1,017,882

                                       5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00069-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00069-of-00352.parquet"}]]